{
  "P532L": {
    "Gene": "BRCA1",
    "Protein_Change": {
      "ref": "P",
      "alt": "L",
      "position": "532"
    },
    "variant_string_id": "BRCA1 P532L",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that BRCA1 mutations lead to defective DNA repair, increasing cancer risk.",
        "judgment": "Yes",
        "reasoning": "The mechanism is clearly defined as loss of function leading to genomic instability."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The assay used was a splicing assay, which directly assesses the functional impact on mRNA processing.",
        "judgment": "Yes",
        "reasoning": "Splicing assays are relevant to the disease mechanism involving BRCA1 function."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The splicing assay included both wild-type and mutant controls, with results performed in triplicate.",
        "judgment": "Yes",
        "reasoning": "Basic controls and replicates were sufficient."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "Statistical analyses showed a significant difference (p < 0.05) in splicing efficiency between wild-type and P532L.",
        "judgment": "Yes",
        "reasoning": "Sufficient statistical analysis supports the functional impact."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The splicing assay demonstrated a significant loss of function for P532L, strongly supporting its pathogenicity."
  }
}